ATE503765T1 - Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon - Google Patents

Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon

Info

Publication number
ATE503765T1
ATE503765T1 AT08701640T AT08701640T ATE503765T1 AT E503765 T1 ATE503765 T1 AT E503765T1 AT 08701640 T AT08701640 T AT 08701640T AT 08701640 T AT08701640 T AT 08701640T AT E503765 T1 ATE503765 T1 AT E503765T1
Authority
AT
Austria
Prior art keywords
polypeptide
transformed
new
vaccine compositions
plasmodium
Prior art date
Application number
AT08701640T
Other languages
English (en)
Inventor
Stanislas Tomavo
Steven Graham Ball
Hulst Christophe D
David Dauvillee
Original Assignee
Centre Nat Rech Scient
Univ Lille Sciences Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Lille Sciences Tech filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE503765T1 publication Critical patent/ATE503765T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT08701640T 2007-01-23 2008-01-23 Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon ATE503765T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0752837A FR2911608B1 (fr) 2007-01-23 2007-01-23 Nouvelles compositions vaccinales anti paludique et ses utilisations.
PCT/EP2008/050758 WO2008090174A1 (fr) 2007-01-23 2008-01-23 Nouvelles compositions vaccinales anti paludique et ses utilisations

Publications (1)

Publication Number Publication Date
ATE503765T1 true ATE503765T1 (de) 2011-04-15

Family

ID=38106252

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08701640T ATE503765T1 (de) 2007-01-23 2008-01-23 Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon

Country Status (7)

Country Link
US (1) US20100199391A1 (de)
EP (1) EP2121736B1 (de)
AT (1) ATE503765T1 (de)
DE (1) DE602008005857D1 (de)
ES (1) ES2363923T3 (de)
FR (1) FR2911608B1 (de)
WO (1) WO2008090174A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0410562B8 (pt) 2003-05-22 2021-05-25 Fralunhofer Usa Inc proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira
EP2352751A2 (de) * 2008-09-28 2011-08-10 Fraunhofer USA, Inc. Plasmodium-impfstoffe, antigene, zusammensetzungen und verfahren
EP2223937A1 (de) * 2009-02-27 2010-09-01 Institut Pasteur Polypeptide zur Vorbeugung oder Behandlung von Malaria
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
KR101774914B1 (ko) * 2012-08-22 2017-09-05 페이스북, 인크. 다수의 사진 공급 스토리용 시스템 및 방법
CN103965320A (zh) * 2013-01-29 2014-08-06 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CA2915122A1 (en) 2013-06-14 2014-12-18 J.R. Simplot Company Protein production in plants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129158A0 (en) * 1996-09-30 2000-02-17 Exseed Genetics L L C Encapsulation of polypeptides within the starch matrix
FR2793806B1 (fr) * 1999-05-21 2003-04-25 Centre Nat Rech Scient Grains d'amidon contenant un polypeptide recombinant d'interet, leur procede d'obtention, et leurs utilisations
US7037681B2 (en) * 2000-02-08 2006-05-02 University Of Hawaii Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
EP1473307A1 (de) * 2003-05-02 2004-11-03 Coöperatieve Verkoop- en Productievereniging, van Aardappelmeel en Derivaten AVEBE B.A. Methode zur Veränderung der Grösse und/oder Morphologie von Stärkekörnern

Also Published As

Publication number Publication date
FR2911608A1 (fr) 2008-07-25
US20100199391A1 (en) 2010-08-05
DE602008005857D1 (de) 2011-05-12
FR2911608B1 (fr) 2009-04-03
WO2008090174A1 (fr) 2008-07-31
EP2121736B1 (de) 2011-03-30
EP2121736A1 (de) 2009-11-25
ES2363923T3 (es) 2011-08-19

Similar Documents

Publication Publication Date Title
UA102867C2 (uk) Антитіла до cxcr4 та їх застосування у лікуванні раку
EA201291067A1 (ru) Гуманизированные антигенсвязывающие белки к миостатину
ATE503765T1 (de) Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon
MY155400A (en) Anti cxcr4 antibodies for the treatment of hiv
CA2813849C (en) Secukinumab for use in the treatment of ankylosing spondylitis
MX357193B (es) Moleculas de union anti-alfa sinucleina.
TN2011000528A1 (en) Compositions and methods for antibodies targeting complement protein c3b
MA32980B1 (fr) Proteines de liaison a la myostatine
SG178886A1 (en) Humanized anti-cdcp1 antibodies
CL2012002095A1 (es) Polipéptido de unión biparatópico que comprende un primer dominio variable individual de inmunoglobulina (ig) que se une específicamente a un primer epítopo del péptido ß-amiloide (ßa) y un segundo dominio variable de ig que se une específicamente a un segundo epítopo del ßa, donde dichos epítopos del ßa no son idénticos; ácido nucleico que lo codifica; vector; célula hospedera; composición farmacéutica; método de preparación; y su uso en el tratamiento y/o prevención de depósitos del ßa
MX2012003939A (es) Fusiones y conjugados de farmaco.
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
UA113623C2 (uk) Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi)
TN2012000466A1 (en) Humanized anti cxcr4 antibodies for the treatment of cancer
NO20083793L (no) Antistoffer mot amyloid-beta peptid
EA201400568A1 (ru) Альбуминсвязывающие антитела и их связывающие фрагменты
NZ593550A (en) ANTI-Siglec-15 ANTIBODY
WO2010085700A3 (en) Treatment for obesity
EA201892184A1 (ru) Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора
WO2009080764A3 (en) Oral or nasal administration of compounds comprising amino acid sequences
BR112013002831A2 (pt) anticorpos direcionados contra a il-17
EA201070725A1 (ru) Бис-пиридилпиридоны как антагонисты рецептора 1 меланинконцентрирующего гормона
BR112014023063A2 (pt) anticorpos que neutralizam rsv, mpv e pvm e usos dos mesmos
PH12012501743A1 (en) Antigen binding proteins specific for serum amyloid p component
WO2010011952A3 (en) Flip death effector domain derived peptides for inducing autophagy

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties